CUTISS

When patients suffer from disastrous large and deep burns, the ability to quickly, affordably and consistently provide large quantities of skin grafts is essential.

Press release

Related Press

A hand holding a bioreactor to grow vein grafts developed by CSEM and ClexBio

22 February 2024

CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants

The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

(Left to Right) A. Schueller, Founder and CEO; This Egloff, Scientist (cellvie); Charlotte Fonta, Senior R&D Engineer; and Gilles Weder, Head R&BD, Life Science Technologies, CSEM.

3 September 2025

Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use

cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...

Deux prototypes d'Active Aligner équipés de diffuseurs antibactériens. Le prototype de droite contient un liquide bleu mettant en évidence l'innovation : un système de microcanaux imprimé en 3D. Celui de gauche représente le prototype d'aligneur transparent dans son apparence finale.

19 September 2024

Dental innovation: Actival and CSEM launch 3D antibacterial aligners

Actival is redefining dental alignment with its innovative 'Active Aligners.' They feature patented 3D-printed microchannel technology developed by CSEM....